V3 LOOP REGION OF THE HIV-1 GP120 ENVELOPE PROTEIN IS ESSENTIAL FOR VIRUS INFECTIVITY

被引:93
|
作者
IVANOFF, LA
DUBAY, JW
MORRIS, JF
ROBERTS, SJ
GUTSHALL, L
STERNBERG, EJ
HUNTER, E
MATTHEWS, TJ
PETTEWAY, SR
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[2] UNIV ALABAMA,DEPT MICROBIOL,UAB STN,BIRMINGHAM,AL 35294
关键词
D O I
10.1016/0042-6822(92)90444-T
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The mechanism by which HIV-1 mediates cell fusion and penetrates target cells, subsequent to receptor (CD4) binding, is not well understood. However, neutralizing antibodies, which recognize the principal neutralizing determinants of the gpl 20 envelope protein (the V3 loop region, residues 296 to 331), have been shown to effectively block cell fusion and virus infectivity independent of the initial gpl20-CD4 binding. To investigate the role of the V3 loop in an HIV infection, a series of site-specific mutations were introduced into the HIV-1 envelope gene. Specifically, each residue (312 to 315) in the strongly conserved tetrapeptide sequence, GPGR, which is positioned in the center of the V3 loop domain was individually altered. The processing, transport, and CD4 binding properties of the mutant envelope proteins were comparable to those of the wild-type protein, however, none of the mutants were able to form syncytia in the HeLa-T4 assay. Molecular HIV-1 clones containing mutations altering the G312, G314, or R315 residues produced noninfectious virions, whereas a clone with a P313A mutation was found to be infectious. These results demonstrate that certain V3 loop mutations can be lethal and clearly indicate that this region of the HIV-1 gpl 20 protein is essential for virus infectivity. © 1992.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 50 条
  • [1] SINGLE AMINO-ACID SUBSTITUTIONS IN THE V3 LOOP REGION OF THE HIV-1 GP120 PROTEIN ALTER VIRUS INFECTIVITY
    IVANOFF, LA
    MORRIS, JF
    STERNBERG, EJ
    GUTSHALL, L
    HUNTER, E
    MATTHEWS, TJ
    PETTEWAY, SR
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 325 - 326
  • [2] Structural Dynamics of HIV-1 Envelope Gp120 Outer Domain with V3 Loop
    Yokoyama, Masaru
    Naganawa, Satoshi
    Yoshimura, Kazuhisa
    Matsushita, Shuzo
    Sato, Hironori
    [J]. PLOS ONE, 2012, 7 (05):
  • [3] EFFECT OF MUTATIONS IN THE V3 LOOP OF HIV-1 GP120 ON INFECTIVITY AND SUSCEPTIBILITY TO PROTEOLYTIC CLEAVAGE
    SCHULZ, TF
    REEVES, JD
    HOAD, JG
    TAILOR, C
    STEPHENS, P
    CLEMENTS, G
    ORTLEPP, S
    PAGE, KA
    MOORE, JP
    WEISS, RA
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (02) : 159 - 166
  • [4] Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope
    Zolla-Pazner, Susan
    Cohen, Sandra Sharpe
    Krachmarov, Chavdar
    Wang, Shixia
    Pinter, Abraham
    Lu, Shan
    [J]. VIROLOGY, 2008, 372 (02) : 233 - 246
  • [5] Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution
    Vranken, WF
    Fant, F
    Budesinsky, M
    Borremans, FAM
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (09): : 2620 - 2628
  • [6] Role of gp120 V3 loop charge in HIV-1 coreceptor selectivity
    Lopez de Victoria, Aliana
    Kieslich, Chris A.
    Shin, David
    Tamamis, Phanourios
    Gonzalez-Rivera, Gloria
    Morikis, Dimitrios
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [7] Sequence variation and consensus sequence of V3 loop on HIV-1 gp120
    Tian, HJ
    Lan, CH
    Chen, YH
    [J]. IMMUNOLOGY LETTERS, 2002, 83 (03) : 231 - 233
  • [8] SURAMIN INHIBITS BINDING OF THE V3 REGION OF HIV-1 ENVELOPE GLYCOPROTEIN GP120 TO GALACTOSYLCERAMIDE, THE RECEPTOR FOR HIV-1 GP120 ON HUMAN COLON EPITHELIAL-CELLS
    YAHI, N
    SABATIER, JM
    NICKEL, P
    MABROUK, K
    GONZALEZSCARANO, F
    FANTINI, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (39) : 24349 - 24353
  • [9] THE COMPLETE CONSENSUS V3 LOOP PEPTIDE OF THE ENVELOPE PROTEIN GP120 OF HIV-1 SHOWS PRONOUNCED HELICAL CHARACTER IN SOLUTION
    VRANKEN, WF
    BUDESINSKY, M
    FANT, F
    BOULEZ, K
    BORREMANS, FAM
    [J]. FEBS LETTERS, 1995, 374 (01) : 117 - 121
  • [10] MODIFICATION OF NEUTROPHILE FUNCTIONAL-ACTIVITY BY SYNTHETIC V3 LOOP PEPTIDE FROM HIV-1 ENVELOPE PROTEIN GP120
    ZEMSKOV, VM
    SUBBOTIN, SM
    VOLKOV, YT
    KIRYUKHIN, AY
    ANDREEV, SM
    NEKHAEV, IV
    UMENKO, EN
    PETRUKHINA, AO
    VAFINA, MG
    MOLODTSOV, NV
    [J]. DOKLADY AKADEMII NAUK, 1995, 344 (01) : 133 - 135